Artemis Medicare Services Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Published 5 Aug 2026 | Healthcare Services | Market Cap: ₹5.1K Cr

Artemis Medicare Services Limited aims to increase bed capacity from current ~700-800 beds to 2,100-2,300 beds by 2029, reflecting strong growth plans. Occupancy expected to rise from current ~62% to 68-70% by end of this financial year, improving revenue and margins.

From Artemis Medicare Services Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

📊 Revenue & Sales Performance

→Artemis Medicare Services Limited aims to increase bed capacity from current ~700-800 beds to 2,100-2,300 beds by 2029, reflecting strong growth plans.
→Organic growth includes adding 200-300 beds phased based on 70% occupancy levels, with incremental operational beds at Gurugram and other facilities.
→Announced projects like Raipur (300 beds) and South Delhi VIMHANS (increasing from 450 to 650 beds) are on track and expected to contribute significantly to revenue.
→International patient revenue grew by 34.9% in the quarter, with volumes rising 35% year-on-year; the company is expanding geographical patient sources.
→ARPOB (Average Revenue Per Occupied Bed) expected to increase 4-6% year-on-year, with plans to maintain or improve this through service mix enhancement.
→New service lines like heart-lung transplants and robotic surgeries aim to drive higher margins and revenues going forward.
→Fundraising of INR 700 crores to fuel inorganic expansion and additional greenfield/brownfield projects in Northern and potentially other regions.

📈 Profitability & Margins

→Occupancy expected to rise from current ~62% to 68-70% by end of this financial year, improving revenue and margins.
→Cost efficiencies anticipated as fixed costs are spread over higher occupancy and Raipur facility costs are allocated separately.
→New quaternary services like heart-lung transplants and robotic surgeries to drive higher-end revenue and margin improvement.
→ARPOB (Average Revenue Per Operating Bed) projected to grow 4-6% YoY sustainably.
→Expected breakeven for Raipur facility within 18-24 months post-launch (April-May 2026).
→Bed capacity to increase significantly, from current 700-800 to 2,000–2,300 by 2029, fueling revenue growth.
→Annual employee cost hike of 4-5% expected; current elevated manpower cost is a peak related to expansion.
→INR 700 crore fundraise will support inorganic and organic expansion, further boosting earnings growth.
→Overall, management confident of improved EBITDA, operating profits, and sustainable EPS growth over next few years.

See what Artemis Medicare Services Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→Capex for Raipur hospital (300 beds) is INR 100 crores, financed through internal accruals and IFC funds; operations expected to start Q1 FY27.
→Capital expenditure for expanding 125 beds at Gurgaon hospital estimated at INR 40-50 lakhs per bed due to existing plinth.
→South Delhi Hospital (VIMHANS) expansion to 650 beds (from 450), with construction starting April/May 2026; capex cost approx. INR 75-80 lakhs per bed; 2.5 years to complete.
→Fundraise of INR 700 crores approved for new hospitals including greenfield and brownfield projects, plus organic expansion of Gurgaon and VIMHANS facilities.
→Aim to increase capacity from 700-800 beds currently to 2,100-2,300 by 2029 using a mix of equity (from fundraise), debt, and accruals.
→Additional projects under evaluation, details expected by June 2026.
→FAR (Floor Area Ratio) approvals obtained to facilitate bed expansions at Gurgaon and other sites.

💰 Fundraising & Capital Structure

- Artemis Medicare Services Limited is planning a new fundraising of INR 700 crores through a mix of QIP (Qualified Institutional Placement) and preferential allotment. - The primary purpose of this fundraise is to support inorganic expansion, including increasing beds at VIMHANS (South Delhi project) from 400 to approximately 650-700 beds, and funding other greenfield and brownfield projects. - Part of the fund will also support organic growth, such as adding 200-300 beds where FAR (Floor Area Ratio) is already obtained or being acquired. - The fundraising is expected to reduce peak debt levels to below INR 300 crores, down from previously guided INR 350-400 crores. - Promoters do not plan to infuse equity; the raise will come from institutional investors via QIP/preferential allotment. - Details on fund deployment and projects are expected to be shared by June 2026. This fundraising complements the company's internal accruals and debt capacity for total investment plans through 2029.

See what Artemis Medicare Services Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

The transcript does not explicitly mention the current or expected orderbook or pending orders for Artemis Medicare Services Limited. However, related insights include: - The company has several announced projects including Raipur facility (300 beds), South Delhi quaternary care hospital (650 beds), and VIMHANS expansion (up to 650-700 beds). - Additional greenfield and brownfield hospital projects are in the pipeline. - A fundraise of INR 700 crores has been approved by the board to fund these new hospital projects and organic expansions. - Bed capacity is planned to increase from ~700 beds currently to around 2,000-2,300 beds by 2029. - The company is finalizing detailed fund deployment plans for these projects. - No specific numeric orderbook or pending order value is disclosed, but multiple projects are underway or planned as part of a strategic growth phase.

Key Metrics

How does Artemis Medicare Services Ltd rank vs peers in Healthcare Services?

Pro feature

1Artemis Medicare Services Ltd

See full Healthcare Services sector rankings

Price

₹326

Market Cap

₹5.1K Cr

P/E Ratio

44.2

Artemis Medicare Services Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹274 Cr, net profit ₹30 Cr.

Full financials →

What Artemis Medicare's management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
CHANDAN (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitals vs Max Healthcare vs Fortis Health.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Artemis Medicare Services Ltd Q3 FY26 results?

What is Artemis Medicare Services Ltd share price analysis?

Artemis Medicare Services Ltd currently shows a neutral. The stock trades at a P/E of 44.2 with a market cap of ₹5,100 Cr. Investors should review the full earnings analysis for detailed insights.

Is Artemis Medicare Services Ltd planning capital expenditure?

Capex for Raipur hospital (300 beds) is INR 100 crores, financed through internal accruals and IFC funds; operations expected to start Q1 FY27.

Keep Artemis Medicare Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.